Last $47.33 USD
Change Today +2.12 / 4.69%
Volume 46.9M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
EN Paris
As of 4:15 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

merck & co. inc. (MRK) Snapshot

Open
$45.24
Previous Close
$45.21
Day High
$47.53
Day Low
$45.19
52 Week High
04/24/13 - $48.79
52 Week Low
05/23/12 - $37.02
Market Cap
142.9B
Average Volume 10 Days
14.8M
EPS TTM
$3.67
Shares Outstanding
3.0B
EX-Date
03/13/13
P/E TM
12.9x
Dividend
$1.72
Dividend Yield
3.59%
Current Stock Chart for MERCK & CO. INC. (MRK)

merck & co. inc. (MRK) Latest News

More News

merck & co. inc. (MRK) Related Businessweek News

View More BusinessWeek News

merck & co. inc. (MRK) Details

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.

83,000 Employees
Last Reported Date: 02/28/13
Founded in 1891

merck & co. inc. (MRK) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.5M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $973.4K
Executive Vice President and President of Glo...
Total Annual Compensation: $938.9K
Executive Vice President and General Counsel
Total Annual Compensation: $791.7K
Compensation as of Fiscal Year 2012.

merck & co. inc. (MRK) Key Developments

The U. S. District Court for the District of New Jersey Dismisses Claims Against Merck & Co. Inc

The U. S. District Court for the District of New Jersey dismissed claims against Merck & Co. Inc., finding that the third-party payors failed to satisfy Article III's traceability requirement. The complaint did not sufficiently plead a causal link between the pharmaceutical company's offering of subsidies to insureds and the third-party payors' alleged increased costs. Merck & Co. Inc. offered coupons and discount cards (collectively, subsidies) that covered a portion, or sometimes all, of the co-pay that privately insured individuals would ordinarily have to pay for certain Merck brand name prescription drugs. Plumbers and Pipefitters Local 572 Health and Welfare Fund and United Food and Commercial Workers International Union, Local 464A Health and Welfare Fund (collectively, third-party payors) sued Merck, alleging the subsidies illegally induced members of the third-party payors to obtain more expensive drugs instead of cheaper, equivalent generic drugs. The complaint further alleged that the subsidies amounted to undisclosed kickbacks to members and interfered with the cost sharing provision in members' contracts with the third-party payors. Merck moved to dismiss, arguing that the third-party payors did not plead an injury that could be traced to Merck's actions. The district court granted the motion. The gravamen of the complaint was that but for the subsidies, a doctor might have prescribed a lower priced drug, the patient might have purchased the lower priced drug and the third-party payors thus would have had lower reimbursement costs. The district court found that the alleged causal link failed. The complaint set forth no allegations that any patient purchased a Merck product because of the subsidies program or that the subsidies caused any doctor to prescribe a drug that he otherwise would not have. In addition, the third-party payors did not allege a specific instance in which they were forced to pay for medication that they would not have paid for but for the subsidies.

Sanford Heisler LLP Files $100 Million Individual and Class Action Suit in the U.S. District Court for New Jersey Against Merck & Co., Inc

Sanford Heisler LLP has filed a $100 million individual and class action suit in the U.S. District Court for New Jersey against Merck & Co. Inc. (MRK). The action was brought by Kelli Smith on behalf of all female sales representatives at Merck. According to the complaint, the company systematically discriminates against its female and pregnant employees in assignment, promotion, advancement, and pay and retaliates against female employees in violation of Title VII of the US Civil Rights Act, the Lilly Ledbetter Fair Pay Act, the Family and Medical Leave Act and the New Jersey Law Against Discrimination. The complaint asserts that employees on maternity leave are ineligible for merit awards and recognition for their sales, even when their sales surpass those of their male counterparts. According to Smith's legal team, Merck has long been on notice about its company-wide gender and pregnancy discrimination, but has taken no steps to remedy them. In fact, the complaint notes that Merck routinely retaliates against women who raise discrimination complaints.

Merck & Co. Inc. Awards Significant Portion of the UNICEF Human Papillomavirus Vaccine Tender

Merck & Co. Inc. announced that the company has been awarded a significant portion of the UNICEF human papillomavirus (HPV) vaccine tender, and will provide sustained supply of GARDASIL(R) [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to GAVI-eligible countries. This agreement follows the GAVI Alliance's earlier announcement that HPV vaccines would be included in its portfolio for the first time. GAVI is expected to support the introduction of HPV vaccination in 28 countries by the end of 2017. GAVI Alliance is a public-private partnership focused on saving children's lives and protecting people's health by increasing access to immunization in poor countries. Through this initial tender award, Merck expects to supply approximately 2.4 million doses of GARDASIL to GAVI-eligible countries between 2013 to 2017 to help meet vaccine demand for countries already approved or recommended for approval by GAVI for HPV vaccine demonstration projects and national introductions. Additional awards by UNICEF are anticipated as vaccine demand increases.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $47.33 USD +2.12

MRK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €84.60 EUR +0.63
GlaxoSmithKline PLC 1,742 GBp +20.50
L'Oreal SA €136.60 EUR +1.25
Roche Holding AG SFr.251.00 CHF +4.00
Sanofi €85.14 EUR +0.83
View Industry Companies
 

Industry Analysis

MRK

Industry Average

Valuation MRK Industry Range
Price/Earnings 23.5x
Price/Sales 3.0x
Price/Book 2.6x
Price/Cash Flow 23.1x
TEV/Sales 2.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit www.merck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.